Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
Combined Inhibition of Endocrine Therapy and the PI3K/AKT/mTOR Pathways Appears Superior to Either Component in HR+ Metastatic Breast Cancer
Login to view comments.
Click here to Login
7th Annual USC Multi-Disciplinary Breast Cancer Symposium